The Yale Fitness Intervention Trial in female cancer survivors: Cardiovascular and physiological outcomes
- PMID: 28803675
- PMCID: PMC6129386
- DOI: 10.1016/j.hrtlng.2017.06.001
The Yale Fitness Intervention Trial in female cancer survivors: Cardiovascular and physiological outcomes
Abstract
Background: Induced premature menopause and cardio-toxic therapy increase cardiovascular disease risk in female cancer survivors.
Objective: To compare the effects of a 12 month aerobic-resistance fitness center intervention to home based physical activity on cardiovascular function and metabolic risk factors.
Methods: Subjects (N = 154) who had completed primary and/or adjuvant chemotherapy (past 3 years) were randomized to a fitness center intervention or a home based group. The fitness center intervention was a structured thrice weekly aerobic (30 min brisk walking treadmill in target heart range) combined with resistance (30 min of lower body strength training) exercise program, supervised for the first 6 months. The home based group received national guidelines for 30 min moderate intensity exercise most days of the week. Fasting serum samples were collected at baseline, 6 and 12 months for insulin, glucose, lipids and hemoglobin A-1C. A graded exercise stress test was also performed at baseline and 6 months.
Results: The majority of subjects were white (85.7%), had breast cancer (83.1%) and the average age was 51.9 years. Subjects in the fitness center intervention had significantly improved time on treadmill (p = .039), improved heart rate recovery at 1 min (p = .028), greater MET minutes/week (p ≤ .0001), a trend for improved insulin resistance (p = .067) and stable insulin levels (p = .045) compared to the home based physical activity group.
Conclusions: Exercise represents a potential cardiac risk reduction intervention for cancer survivors. CLINICAL TRIALS.GOV: NCT01102985.
Keywords: Breast cancer; Cardiovascular fitness; Exercise; Heart rate recovery; Insulin resistance.
Copyright © 2017. Published by Elsevier Inc.
Figures
References
-
- Khakoo AY, Yeh ET. Therapy insight: management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Nat Clin Pract Oncol. 2008;5(11):655. - PubMed
-
- Crawford SL, Casey VA, Avis NE, McKinlay SM. A longitudinal study of weight and menopause transition: results from the Massachusetts women’s health study. Menopause. 2000;7:96. - PubMed
-
- Jones LW, Haykowsky M, Peddle CJ, et al. Cardiovascular risk profile of patients with HER2/neu-positive breast cancer treated with anthracycline-taxane-containing adjuvant chemotherapy and/or trastuzumab. Cancer Epidemiol Biomark Prev. 2007;16:1026. - PubMed
-
- Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50:1435. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous